Time and Date
September 20, 2024
11:00 am – 12:00 pm Eastern Time
Synopsis
This webinar discusses the current situation of the multi-country mpox outbreaks and the potential implications for Canadian public health. The learning objectives include:
- Epidemiological overview of mpox infections in the global and Canadian contexts.
- Updates in the clinical presentation of mpox infections.
- Overview of the National Advisory Committee on Immunization (NACI) Interim Guidance on the use of Imvamune in the context of a routine immunization program.
Moderator: Dr. Wendy Xie, Project Manager, NCCID
Speakers
Dr. Darrell Tan, MD, FRCPC, PhD
Darrell H. S. Tan is an infectious diseases physician and Clinician-Scientist at St. Michael’s Hospital, where he leads the Options Collaboratory in HIV/STI Treatment and Prevention Science (www.optionslab.ca). He is also an Associate Professor in the Department of Medicine and Institute of Health Policy, Management and Evaluation at the University of Toronto, with a cross-appointment in the Institute of Medical Science. His research focuses on clinical trials and implementation science in the areas of HIV prevention, HIV treatment and sexually transmitted infections (STIs). Dr. Tan holds a Tier 2 Canada Research Chair in HIV Prevention and STIs, is Co-Lead of the HIV Prevention Core of the CIHR Canadian HIV Trials Network and is a member of the Governing Council of the International AIDS Society.
Joshua Montroy, MSc
Josh is a scientific project coordinator for the NACI secretariat, within the infectious diseases and vaccine programs branch at the Public Health Agency of Canada. He holds a master’s degree in epidemiology and community medicine from the University of Ottawa, where he trained with the Centre for Transfusion Research.
Registration link: https://unbc.zoom.us/webinar/register/WN_eysBL9JiSHqLt-4Ifij_OA